Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies

Skip Nav Destination

Cancer Res (2017) 77 (23): 6717–6728.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

COVID-19 vaccine incentive scheduling using an optimally controlled reinforcement learning model

K. Stuckey
P.K. Newton

Physica D: Nonlinear Phenomena (2023) 445: 133613.

Stochastic competitive release and adaptive chemotherapy

J. Park
P. K. Newton

Physical Review E (2023) 108 (3)

Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory

Lei Zhang
Jianli Ma
Lei Liu
Guozheng Li
Hui Li
Yi Hao
Xin Zhang
Xin Ma
Yihai Chen
Jiale Wu
Xinheng Wang
Shuai Yang
Shouping Xu

Critical Reviews in Oncology/Hematology (2023) 192: 104192.

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma

Yuting Huang
Jing Chang
Xiaolei Guo
Chao Zhang
Wenping Ji
Shusheng Zhou
Chao Wang
Xu Zhang

Frontiers in Oncology (2022) 12

Organelle-inspired supramolecular nanomedicine to precisely abolish liver tumor growth and metastasis

Jie Zhan
Yuhan Wang
Shaodan Ma
Qin Qin
Ling Wang
Yanbin Cai
Zhimou Yang

Bioactive Materials (2022) 9: 120.

Role of synergy and antagonism in designing multidrug adaptive chemotherapy schedules

Y. Ma
P. K. Newton

Physical Review E (2021) 103 (3)

Are Adaptive Chemotherapy Schedules Robust? A Three-Strategy Stochastic Evolutionary Game Theory Model

Rajvir Dua
Yongqian Ma
Paul K. Newton

Cancers (2021) 13 (12): 2880.

Evaluation of solid tumor response to sequential treatment cycles via a new computational hybrid approach

Farshad Moradi Kashkooli
M. Soltani

Scientific Reports (2021) 11 (1)

Growth rate, growth curve and growth prediction of tumour in the competitive model

Mahdi Sohrabi-Haghighat
Atefeh Deris

Mathematical and Computer Modelling of Dynamical Systems (2020) 26 (2): 193.

A Quasi Birth-and-Death model for tumor recurrence

Leonardo M. Santana
Shridar Ganesan
Gyan Bhanot

Journal of Theoretical Biology (2019) 480: 175.

Nonlinear adaptive control of competitive release and chemotherapeutic resistance

P. K. Newton
Y. Ma

Physical Review E (2019) 99 (2)

The pro-tumorigenic host response to cancer therapies

Yuval Shaked

Nature Reviews Cancer (2019) 19 (12): 667.

The Immune Checkpoint Kick Start: Optimization of Neoadjuvant Combination Therapy Using Game Theory

Jeffrey West
Mark Robertson-Tessi
Kimberly Luddy
Derek S. Park
Drew F.K. Williamson
Cathal Harmon
Hung T. Khong
Joel Brown
Alexander R.A. Anderson

JCO Clinical Cancer Informatics (2019) (3): 1.

Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment

Jeffrey West
Yongqian Ma
Paul K. Newton

Journal of Theoretical Biology (2018) 455: 249.

Pharmacokinetic/pharmacodynamic modeling of combination-chemotherapy for lung cancer

Louis T. Curtis
Victor H. van Berkel
Hermann B. Frieboes

Journal of Theoretical Biology (2018) 448: 38.

Role of textural heterogeneity parameters in patient selection for 177Lu-PSMA therapy via response prediction

Zain Khurshid
Hojjat Ahmadzadehfar
Florian C. Gaertner
László Papp
Norbert Zsóter
Markus Essler
Ralph A. Bundschuh

Oncotarget (2018) 9 (70): 33312.

Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies

AACR Journals

This Feature Is Available To Subscribers Only